Severe hemorrhage in a patient with metastatic colorectal cancer

被引:5
|
作者
Oergel, Melanie [1 ]
Horger, Marius [2 ]
Kurth, Ralph [3 ]
Kanz, Lothar [1 ]
Jaschonek, Karl [1 ]
Mayer, Frank [1 ]
Kopp, Hans-Georg [1 ]
机构
[1] Univ Klinikum Tubingen, Med Klin, Tubingen, Germany
[2] Univ Klinikum Tubingen, Radiol Klin, Tubingen, Germany
[3] Univ Klinikum Tubingen, Inst Allgemeine Pathol, Tubingen, Germany
关键词
Colorectal Cancer; Microangiopathic Hemolysis; Disseminated Intravascular Cogulation; DISSEMINATED INTRAVASCULAR COAGULATION; BONE-MARROW; GASTRIC-CANCER; BREAST-CANCER; SOLID TUMORS; MALIGNANCY; STATE; THROMBOCYTOPENIA;
D O I
10.1055/s-0032-1305227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
History and admission findings: We report on a 65-year-old female patient with a recent diagnosis of adenocarcinoma of the sigmoid colon and massive hematochezia in the context of a general bleeding disorder. Investigations: Disseminated malignant disease with hepatic metastases as well as bone marrow involvement was demonstrated. Moreover, circulating tumor cells were demonstrated by flow cytometry. The patient had right lower quadrant abdominal pain due to a spontaneous psoas intramuscular hematoma. Diagnosis, treatment and course: At the time of admission to our hospital, the patient displayed microangiopathic hemolytic anemia and secondary hyperfibrinolysis with a pronounced bleeding tendency. Moreover, there was an acute renal failure which improved with fluid resuscitation. With immediate chemotherapy consisting of 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX regimen) and cetuximab initiated with the second course, plasmatic coagulation could be stabilized. Consequently, treatment with tranexamic acid, fibrinogen, fresh frozen plasma as well as red blood cell and platelet infusions could be stopped. Continuation of chemotherapy was possible on an outpatient basis and the further course was associated with a good quality of life until her near end. The patient died at home 7 months after initial diagnosis of her colon cancer due to progressive disease with CNS metastases. Conclusions: Disseminated intravascular coagulation with microangiopathic hemolysis and secondary hyperfibrinolysis is a rare albeit possible event in disseminated colorectal cancer, especially when the bone marrow is involved. Treatment of the underlying cause is the most important therapeutic measure.
引用
收藏
页码:1705 / +
页数:36
相关论文
共 50 条
  • [1] Intraarticular hemorrhage due to bevacizumab in a patient with metastatic colorectal cancer: a case report
    Mukremin Uysal
    Sema Sezgin Goksu
    Hasan Senol Coskun
    Burhan Savas
    Mustafa Ozdogan
    Hakan Bozcuk
    Journal of Medical Case Reports, 6 (1)
  • [2] Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer
    Shu, Yefei
    Zheng, Song
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction: A case report
    Tsuchihashi, Kenji
    Shimokawa, Hozumi
    Takayoshi, Kotoe
    Nio, Kenta
    Aikawa, Tomomi
    Matsushita, Yuzo
    Wada, Iori
    Arita, Shuji
    Ariyama, Hiroshi
    Kusaba, Hitoshi
    Sonoda, Koh-Hei
    Akashi, Koichi
    Baba, Eishi
    MEDICINE, 2017, 96 (42)
  • [4] Cetuximab treatment in a patient with metastatic colorectal cancer and psoriasis
    Neyns, B.
    Meert, V.
    Vandenbroucke, E.
    CURRENT ONCOLOGY, 2008, 15 (04) : 196 - 197
  • [5] Severe Cardiotoxicity in a Patient with Colorectal Cancer Treated with Bevacizumab
    Chen, Jian
    Du, Fengcai
    Hu, Baohong
    Chi, Cheng
    Chu, Hongjin
    Jiang, Lixin
    Li, Peng
    Gong, Zhaohua
    ANTICANCER RESEARCH, 2017, 37 (08) : 4557 - 4561
  • [6] Successful oxaliplatin desensitization protocol in a patient with colorectal metastatic cancer
    de Lira-Quezada, Cindy E.
    Villarreal-Gonzalez, Rosalaura V.
    Gonzalez-Diaz, Sandra N.
    Carrasco-Diaz, Ligia L.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (02) : 490 - 493
  • [7] Nephrotic syndrome induced by cetuximab in a patient with metastatic colorectal cancer
    Korkmaz, Mustafa
    Hendem, Engin
    Eryilmaz, Melek Karakurt
    Demirkiran, Aykut
    Karaagac, Mustafa
    Artac, Mehmet
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (04) : 998 - 1002
  • [8] Metastatic colorectal cancer
    Kindler H.L.
    Shulman K.L.
    Current Treatment Options in Oncology, 2001, 2 (6) : 459 - 471
  • [9] Establishing metastatic patient-derived xenograft model for colorectal cancer
    Zhang, Yanmei
    Lee, Sau Har
    Wang, Cheng
    Gao, Yunhe
    Li, Jiyang
    Xu, Wei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (10) : 1108 - 1116
  • [10] The updates on metastatic mechanism and treatment of colorectal cancer
    Ni, Yunfei
    Liang, You
    Li, Mingzhou
    Lin, Yang
    Zou, Xin
    Han, Fangyi
    Cao, Jianing
    Li, Liang
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 251